# Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

> **NCT06753994** · PHASE1 · RECRUITING · sponsor: **McGill University** · enrollment: 24 (estimated)

## Conditions studied

- Diabetes
- Type1diabetes
- T1D

## Interventions

- **DRUG:** SGLT-2 inhibitor

## Key facts

- **NCT ID:** NCT06753994
- **Lead sponsor:** McGill University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-05
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06753994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06753994, "Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06753994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*